STERIS plc STE

Latest FY: 2026 Healthcare Medical Devices
Market Price $233.20
Market Cap $23.04B
P/E Ratio 29.41
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↑8.7% YoY
$5.94B
3-Yr CAGR: 1,177.4%
Net Income ↑27.4% YoY
$785.10M
Net Margin: 13.2%
Free Cash Flow ↑24.9% YoY
$982.90M
FCF Yield: 4.27%
EPS (Diluted) ↑27.9% YoY
$7.93
Basic: $7.97
Return on Equity Efficiency
10.9%
ROA: 340.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (STE)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $2,620.0M $1,092.7M $291.6M $3.39 $457.6M
FY 2019 $768.2M -70.7% $674.5M $305.1M +4.6% $3.56 +5.0% $539.5M $349.8M
FY 2020 $823.0M +7.1% $1,319.9M $407.8M +33.7% $4.76 +33.7% $590.6M $376.0M +7.5%
FY 2021 $873.5M +6.1% $1,343.1M $396.9M -2.7% $4.63 -2.7% $689.6M $450.4M +19.8%
FY 2022 $1,210.7M +38.6% $557.4M $242.9M -38.8% $2.48 -46.4% $684.8M $397.2M -11.8%
FY 2023 $2.8M -99.8% $2,159.7M $105.8M -56.4% $1.07 -56.9% $756.9M $409.6M +3.1%
FY 2024 $1,419.4M +49,738.0% $1,082.9M $380.1M +259.2% $3.81 +256.1% $973.3M $620.4M +51.5%
FY 2025 $5,459.5M +284.6% $2,402.8M $616.1M +62.1% $6.20 +62.7% $1,148.1M $787.2M +26.9%
FY 2026 $5,935.9M +8.7% $2,626.5M $785.1M +27.4% $7.93 +27.9% $1,341.4M $982.9M +24.9%
$

Valuation

Market Price $233.20
Market Cap $23.04B
Enterprise Value $22.75B
P/E Ratio 29.41
P/B Ratio 3.17
FCF Yield 4.27%
Dividend Yield N/A
Shares Outstanding 97,602,500
%

Profitability & Margins

Gross Margin 44.25%
Operating Margin 30.87%
Net Margin 13.23%
Return on Equity (ROE) 10.93%
Return on Assets (ROA) 340.76%
Asset Turnover 25.76x
Revenue 3-Yr CAGR 1,177.37%
🛡️

Financial Health & Liquidity

Current Ratio 0.20
Cash Ratio 0.38
Debt / Equity 0.022
Debt / Assets 0.671
Cash & Equivalents $439.60M
Total Debt $154.70M
Book Value / Share $73.60
💧

Cash Flow Efficiency

Operating Cash Flow $1.34B
Capital Expenditures (CapEx) $358.50M
Free Cash Flow $982.90M
OCF / Revenue 22.60%
FCF / Revenue 16.56%
FCF 3-Yr CAGR 33.88%
🏷️

Per Share Metrics

EPS (Diluted) $7.93
EPS (Basic) $7.97
Dividends / Share N/A
Book Value / Share $73.60
EPS YoY Growth 27.90%
🏛️

Balance Sheet (FY 2026)

Total Assets $230.40M
Total Liabilities $3.54B
Stockholders' Equity $7.18B
Current Assets $230.40M
Current Liabilities $1.15B